Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced financial ...
Exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results